about
Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells.Improvement of DC vaccine with ALA-PDT induced immunogenic apoptotic cells for skin squamous cell carcinoma.The Application of Cytidyl Guanosyl Oligodeoxynucleotide Can Affect the Antitumor Immune Response Induced by a Combined Protocol of Cryoablation and Dendritic Cells in Lewis Lung Cancer Model.Targeting breast cancer stem cells by dendritic cell vaccination in humanized mice with breast tumor: preliminary results.Enhanced function of cytotoxic T lymphocytes induced by dendritic cells modified with truncated PSMA and 4-1BBL.Co-expression of CD40L with CD70 or OX40L increases B-cell viability and antitumor efficacy.In vitro transfection of bone marrow-derived dendritic cells with TATp-liposomes.A review of dendritic cell therapy for cancer: progress and challenges.Oncolytic vaccines.Dendritic cell-based vaccines: clinical applications in breast cancer.Lipopolysaccharide-primed heterotolerant dendritic cells suppress experimental autoimmune uveoretinitis by multiple mechanisms.A suppressor of cytokine signaling 1 antagonist enhances antigen-presenting capacity and tumor cell antigen-specific cytotoxic T lymphocyte responses by human monocyte-derived dendritic cells.Potent anti-prostate cancer immune response induced by dendritic cells transduced with recombinant adenoviruses encoding 4-1BBL combined with cytokine-induced killer cells.Effect of age on chronic inflammation and responsiveness to bacterial and viral challenges.Strategies to Genetically Modulate Dendritic Cells to Potentiate Anti-Tumor Responses in Hematologic Malignancies.Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer.
P2860
Q33761585-F18092C0-9A02-4FE4-A846-03D13AE2689DQ36231990-B04E0D17-E3E5-42F0-9D42-74C81D273115Q36820908-6D596B6A-12B2-4367-924C-53A3C1F352AFQ37123297-45F80618-8680-456C-89E6-BDD915772ACCQ37521861-847DD648-225F-457D-BEA1-BB757B40A2E9Q37564683-81860E9A-7116-40D4-8BDD-8E9EDF510A44Q37591900-4592D353-9B53-4332-A1DA-FB8618A8099AQ38099612-C5857405-D461-4540-AD32-3623DC56A8FEQ38152474-CFB226CA-02A4-4314-AB33-B6D1FACDD6ADQ38206821-349026D7-7FFB-477C-9B53-2C8604557A71Q41766647-BE7597A1-084C-4249-8F59-6EC349D42D92Q41867724-46D7FCAC-971A-4ABB-BEB6-92E22CD7D8D7Q42175389-E087A1A0-382C-4582-A39A-7E6967A7D9BDQ47094909-D633F572-4660-42CA-9A93-8D1EFEC62648Q55003884-8C0AD066-169E-4356-8147-B7677B92CA39Q55174561-15556254-5EB8-4EAA-BA50-553E793B738C
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Enhancement of dendritic cells as vaccines for cancer
@ast
Enhancement of dendritic cells as vaccines for cancer
@en
type
label
Enhancement of dendritic cells as vaccines for cancer
@ast
Enhancement of dendritic cells as vaccines for cancer
@en
prefLabel
Enhancement of dendritic cells as vaccines for cancer
@ast
Enhancement of dendritic cells as vaccines for cancer
@en
P2860
P356
P1433
P1476
Enhancement of dendritic cells as vaccines for cancer
@en
P2093
Cliona M Rooney
Meghan E Turnis
P2860
P304
P356
10.2217/IMT.10.56
P577
2010-11-01T00:00:00Z